Back to Search
Start Over
Rituximab-Associated Progressive Multifocal Leukoencephalopathy: A Twenty-Year Update.
- Source :
-
Cancer treatment and research [Cancer Treat Res] 2022; Vol. 184, pp. 103-111. - Publication Year :
- 2022
-
Abstract
- Progressive multifocal leukoencephalopathy (PML) is a John-Cunningham virus-related central nervous system that is rarely observed in persons treated with the anti-CD20 monoclonal antibody, rituximab.<br /> (© 2022. The Author(s), under exclusive license to Springer Nature Switzerland AG.)
Details
- Language :
- English
- ISSN :
- 0927-3042
- Volume :
- 184
- Database :
- MEDLINE
- Journal :
- Cancer treatment and research
- Publication Type :
- Academic Journal
- Accession number :
- 36449191
- Full Text :
- https://doi.org/10.1007/978-3-031-04402-1_7